Singapore Paincare Holdings Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Singapore Paincare Holdings şu anda temettü ödemiyor.

Anahtar bilgiler

Temettü verimi

Geri Alım Getirisi

Toplam Hissedar Getirisi	0%
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	S$0.0035
Ödeme oranı	0%

Son temettü ve geri alım güncellemeleri

Recent updates

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: FRQ şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: FRQ şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Singapore Paincare Holdings Piyasaya Karşı Temettü Getirisi

FRQ temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (FRQ)	0%
Pazarın Alt %25'i (SG)	2.7%
Pazarın En İyi %25'i (SG)	6.0%
Sektör Ortalaması (Healthcare)	3.4%
Analist tahmini (FRQ) (3 yıla kadar)	n/a

Önemli Temettü: FRQ şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, FRQ şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: FRQ SG piyasası için dikkate değer bir temettü ödemiyor.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: FRQ herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

Singapore Paincare Holdings Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü ve geri alım güncellemeleri

Singapore Paincare Holdings Limited Proposes Final Dividend (Tax Exempt One-Tier) for the Financial Year Ended 30 June 2023, Payable on November 17, 2023

Singapore Paincare Holdings Limited Proposes Final Dividend (Tax Exempt One-Tier) for the Financial Year Ended 30 June 2023

Upcoming dividend of S$0.012 per share

Singapore Paincare Holdings Limited Approves Final Dividend (Tax-Exempt One-Tier) for the Financial Year Ended 30 June 2022

Singapore Paincare Holdings Limited Recommends Final Dividend

Recent updates

Full year 2024 earnings released: EPS: S$0.011 (vs S$0.004 loss in FY 2023)

Singapore Paincare Holdings Limited, Annual General Meeting, Oct 25, 2024

Singapore Paincare Holdings Limited Announces Changes to the Composition of the Board

Full year 2024 earnings released: EPS: S$0.012 (vs S$0.003 loss in FY 2023)

Singapore Paincare Holdings Limited Appoints Isaac Peh Lin Siah as Financial Controller, Effective August 22, 2024

New minor risk - Dividend sustainability

Now 23% undervalued

High number of new directors

Singapore Paincare Holdings Limited Announces the Appointment of Soh Chiong Siong as Financial Controller, Effective April 22, 2024

Insufficient new directors

Now 22% undervalued after recent price drop

Singapore Paincare Holdings Limited Announces Yap Beng Tat, Richard Resigns as Independent Non-Executive Director

Singapore Paincare Holdings Limited Announces Resignation of Lim Mong Ai, Karen as Financial Controller

Now 20% undervalued

Singapore Paincare Holdings Limited Proposes Final Dividend (Tax Exempt One-Tier) for the Financial Year Ended 30 June 2023, Payable on November 17, 2023

Full year 2023 earnings released: S$0.003 loss per share (vs S$0.022 profit in FY 2022)

Singapore Paincare Holdings Limited Proposes Final Dividend (Tax Exempt One-Tier) for the Financial Year Ended 30 June 2023

Singapore Paincare Holdings Limited, Annual General Meeting, Oct 27, 2023

Full year 2023 earnings released: S$0.003 loss per share (vs S$0.022 profit in FY 2022)

Singapore Paincare Holdings Limited to Report Fiscal Year 2023 Results on Aug 29, 2023

New minor risk - Financial data availability

Singapore Paincare Holdings Limited Appoints Lim Mong Ai, Karen as Financial Controller, Effective July 1, 2023

First half 2023 earnings released

Singapore Paincare Holdings Limited Appoints Lim Kah Meng as Chairman of the Remuneration Committee and A Member of the Audit Committee and the Nominating Committee

Upcoming dividend of S$0.012 per share

Singapore Paincare Holdings Limited Approves Final Dividend (Tax-Exempt One-Tier) for the Financial Year Ended 30 June 2022

Full year 2022 earnings released: EPS: S$0.022 (vs S$0.013 in FY 2021)

Singapore Paincare Holdings Limited Announces Cessation of Chong Weng Hoe as Independent Non-Executive Director, Chairman of Remuneration Committee and Member of the Audit Committee and Nominating Committee

Full year 2022 earnings released: EPS: S$0.022 (vs S$0.013 in FY 2021)

Singapore Paincare Holdings Limited Recommends Final Dividend

Singapore Paincare Holdings Limited Announces Promotion of Leow Yong Kin from Financial Controller to Chief Financial Officer

High number of new and inexperienced directors

High number of new and inexperienced directors

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Full year 2021 earnings released: EPS S$0.013 (vs S$0.031 in FY 2020)

Full year 2021 earnings released: EPS S$0.013 (vs S$0.031 in FY 2020)

Singapore Paincare Holdings Limited Appoints Dr. Lim Kah Meng as Independent Non-Executive Director

First half 2021 earnings released: EPS S$0.004 (vs S$0.01 in 1H 2020)

Singapore Paincare Holdings Limited (Catalist:FRQ) completed the acquisition of 40% stake in KCS Anaesthesia Services Pte. Ltd from Kong Chee Sang.

New 90-day high: S$0.23

Singapore Paincare Holdings Limited (Catalist:FRQ) agreed to acquire 40% stake in Kong Chee Seng fro SGD 2.4 million.

Singapore Paincare Holdings Limited has completed a Follow-on Equity Offering in the amount of SGD 3.96 million.

Full year earnings released - EPS S$0.031

Singapore Paincare Holdings Limited (Catalist:FRQ) entered into agreement to acquire AE Medical Sengkang Private Limited from Wong Shing Yip for SGD 0.17 million.

Singapore Paincare Holdings Limited has completed an IPO in the amount of SGD 5.33412 million.

Ödemelerde İstikrar ve Büyüme

Piyasaya Karşı Temettü Getirisi

Hissedarlara Ödenen Kazanç

Hissedarlara Nakit Ödeme

Güçlü temettü ödeyen şirketleri keşfedin